Publicacións en colaboración con investigadores/as de Institute Catalá Oncología (9)

2024

  1. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer

    JAMA network open, Vol. 7, Núm. 4, pp. e247811

2023

  1. SEOM clinical guideline on heritable TP53-related cancer syndrome (2022)

    Clinical and Translational Oncology, Vol. 25, Núm. 9, pp. 2627-2633

2018

  1. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain

    Psycho-Oncology, Vol. 27, Núm. 6, pp. 1530-1537

2011

  1. Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry

    Breast Cancer Research and Treatment, Vol. 128, Núm. 2, pp. 573-579

  2. SEOM clinical guidelines for hereditary cancer

    Clinical and Translational Oncology, Vol. 13, Núm. 8, pp. 580-586

2009

  1. Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort

    Human Reproduction, Vol. 24, Núm. 4, pp. 1000-1006

  2. Xeroderma pigmentosum: Neck lymph node metastasis of a squamous cell carcinoma of the skin treated with cetuximab

    European Journal of Dermatology, Vol. 19, Núm. 2, pp. 163-165

2008

  1. BRCA1 and acetyl-CoA carboxylase: The metabolic syndrome of breast cancer

    Molecular Carcinogenesis, Vol. 47, Núm. 2, pp. 157-163

  2. The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain

    Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869